Lancet
-
Clinical Trial
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.
Carotid baroreflex activation lowers blood pressure and might have potential application for the treatment of resistant hypertension. We did a proof-of-principle trial with a novel endovascular baroreceptor amplification device, MobiusHD (Vascular Dynamics, Mountain View, CA, USA), in patients with resistant hypertension. ⋯ Vascular Dynamics.